Latest Earnings Results: Q3 '26
Estimated EPS
$1.36
Reported EPS
$1.56
Surprise
+14.65%
Estimated Rev
$3.48B
Reported Rev
$3.47B
Surprise
-0.15%
Henry Schein raised FY2026 non-GAAP diluted EPS guidance to $5.50 to $5.56 and Adjusted EBITDA growth to high-single-digits; total sales growth guidance remains 4.5% to 5.5%.
Bullish Takeaway
Henry Schein recorded U.S. dental merchandise growth from volume and market share gains, Global Technology sales growth alongside a business-disposal decrease, and Adjusted EBITDA growth with higher margin.
Bearish Takeaway
Henry Schein reported declining Global Value-Added Services sales, included a tariff-refund benefit while assuming no significant future refunds or remeasurement gains, and identified third-party supply and cybersecurity risks.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $1.43 | -- | -- | N/A |
Q3 '26 | $1.36 | $1.56 | 14.65% | BEAT |
Q2 '26 | $1.24 | $1.27 | 2.46% | BEAT |
Q1 '26 | $1.22 | $1.32 | 8.38% | BEAT |
Q4 '25 | $1.30 | $1.34 | 3.02% | BEAT |